LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 46 filers reported holding LARIMAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,434,796 | +45.0% | 616,306 | +14.9% | 0.00% | – |
| Q2 2023 | $1,679,432 | +36.3% | 536,560 | +97.3% | 0.00% | – |
| Q1 2023 | $1,231,996 | +129175.6% | 271,964 | +17.8% | 0.00% | – |
| Q4 2022 | $953 | -99.7% | 230,791 | +102.6% | 0.00% | – |
| Q3 2022 | $364,000 | +63.2% | 113,890 | 0.0% | 0.00% | – |
| Q2 2022 | $223,000 | -51.6% | 113,890 | 0.0% | 0.00% | – |
| Q1 2022 | $461,000 | -62.5% | 113,890 | 0.0% | 0.00% | – |
| Q4 2021 | $1,228,000 | -6.6% | 113,890 | -0.1% | 0.00% | – |
| Q3 2021 | $1,315,000 | +19.1% | 114,060 | +1.4% | 0.00% | – |
| Q2 2021 | $1,104,000 | -25.5% | 112,454 | +10.9% | 0.00% | – |
| Q1 2021 | $1,481,000 | -19.0% | 101,434 | +18.8% | 0.00% | – |
| Q4 2020 | $1,828,000 | +75.9% | 85,407 | +24.7% | 0.00% | – |
| Q3 2020 | $1,039,000 | +213.0% | 68,493 | +164.8% | 0.00% | – |
| Q2 2020 | $332,000 | – | 25,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,515,148 | $32,439,000 | 9.14% |
| ACUTA CAPITAL PARTNERS, LLC | 863,100 | $18,479,000 | 5.03% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 217,203 | $4,650,000 | 2.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,144,539 | $110,145,000 | 2.18% |
| Atlas Venture Advisors, Inc. | 292,184 | $6,256,000 | 1.40% |
| Logos Global Management LP | 715,000 | $15,308,000 | 1.31% |
| Sio Capital Management, LLC | 188,661 | $4,039,000 | 0.83% |
| Vivo Capital, LLC | 799,662 | $17,121,000 | 0.76% |
| Altium Capital Management LP | 93,261 | $1,997,000 | 0.75% |
| RA Capital Management | 1,515,151 | $32,439,000 | 0.45% |